Clinical Trial Update: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing a combination regimen including filgrastim, cladribine, cytarabine, mitoxantrone, and sorafenib in newly diagnosed acute myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Biphenotypic Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cladribine (cladribine)
• Filgrastim (filgrastim)
• Mitoxantrone (mitoxantrone)
• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Washington | Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-06-29